Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of ... Mondaq News Alerts (registration) The European Medicines Agency ("EMEA") made its biosimilar monoclonal antibody guidelines effective in December 20121. Less than a year later, in September 2013, it approved Europe's first biosimilar antibody. The drug is Inflectra which is a ... |
